KCP
MRK icon

Kera Capital Partners’s Merck MRK Stock Holding History

Kera Capital Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35M Sell
18,314
-723
-4% -$84.6K 0.23% 60
2026
Q1 		$2.29M Sell
19,037
-221
-1% -$25.5K 0.28% 53
2025
Q4 		$2.12M Buy
19,258
+1,604
+9% +$151K 0.26% 57
2025
Q3 		$1.48M Buy
17,654
+9,382
+113% +$773K 0.22% 63
2025
Q2 		$655K Buy
8,272
+4,420
+115% +$351K 0.13% 69
2025
Q1 		$346K Buy
3,852
+282
+8% +$26.3K 0.1% 77
2024
Q4 		$355K Buy
+3,570
New +$368K 0.1% 72

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kera Capital Partners's MRK Position: Q2 2026 in Review

Kera Capital Partners reduced its Merck (MRK) stake by 3.8% in Q2 2026, selling an estimated $84.6K and leaving 18,314 shares worth $2.35M. The position accounts for 0.23% of the portfolio, ranked #60.

Kera Capital Partners first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,847 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Kera Capital Partners held 18,314 shares of Merck worth $2.35M as of Q2 2026.
  • Kera Capital Partners sold 723 Merck shares in Q2 2026, an estimated $84.6K.
  • Merck made up 0.23% of Kera Capital Partners's portfolio in Q2 2026, its #60 holding.
  • Kera Capital Partners first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,847 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Kera Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.